Radiofrequency Ablation in Treating Patients With Bone Metastases
Completed · Not applicable
Conditions studied: Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Radiofrequency ablation may be effective in decreasing pain from bone metastases. PURPOSE: Phase I/II trial to study the effectiveness of radiofrequency ablation in decreasing pain in patients who have bone metastases.
Key facts
- Study ID
- NCT00026247
- Run by
- American College of Radiology Imaging Network
- People needed
- 66
- Starts
- 2001-11-01
- Expected to finish
- 2010-02-15
- Last updated by the study team
- 2019-07-05
Who can join
Age: 21 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Comprehensive Cancer Center at University of Alabama at Birmingham — Birmingham, Alabama, United States
- UMASS Memorial Cancer Center - University Campus — Worcester, Massachusetts, United States
- Mallinckrodt Institute of Radiology at Washington University Medical Center — St Louis, Missouri, United States
- Radiology Consultants, Incorporated — Youngstown, Ohio, United States
- Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania, United States
- Kimmel Cancer Center at Thomas Jefferson University - Philadelphia — Philadelphia, Pennsylvania, United States
- Comprehensive Cancer Center at Rhode Island Hospital — Providence, Rhode Island, United States
- M.D. Anderson Cancer Center at University of Texas — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.